Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Incidence of CNS tumors appears lower in Chinese children

Key clinical point: The incidence of central nervous system (CNS) tumors appears lower in Chinese children compared with children of Asian/Pacific Islander descent and children of all ethnicities in the United States.

Major finding: Adjusted incidence rates of CNS tumors were significantly higher in the U.S. cohorts than in the cohort of children from Hong Kong (P < .001). The rates were 2.51 per 100,000 in the Hong Kong cohort, 3.26 per 100,000 in the U.S. Asian/Pacific Islander cohort, and 4.10 per 100,000 in the U.S. cohort including all ethnicities.

Study details: A population-based cohort study including 508 Hong Kong patients of Chinese descent, 447 U.S. patients of Asian/Pacific Islander descent, and 5,047 U.S. patients of any ethnicity, all with CNS tumors.

Disclosures: The study was supported by the American Lebanese Syrian Associated Charities and the Children’s Cancer Foundation, Hong Kong. The authors disclosed affiliations with MSD Oncology, Genentech, and Kazia.

Citation:

Liu APY et al. JCO Glob Oncol. 2020 May 11. doi: 10.1200/JGO.19.00378.